Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting.
Torti C, Casari S, Palvarini L, Quiros-Roldan E, Moretti F, Leone L, Patroni A, Castelli F, Ripamonti D, Tramarin A, Carosi G. Torti C, et al. Among authors: patroni a. Health Policy. 2003 Sep;65(3):261-7. doi: 10.1016/s0168-8510(03)00002-2. Health Policy. 2003. PMID: 12941493
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Torti C, Maggiolo F, Patroni A, Suter F, Ladisa N, Paraninfo G, Pierotti P, Orani AM, Minoli L, Arici C, Sighinolfi L, Tinelli C, Carosi G; MASTER Cohort. Torti C, et al. Among authors: patroni a. J Antimicrob Chemother. 2005 Jul;56(1):190-5. doi: 10.1093/jac/dki172. Epub 2005 May 25. J Antimicrob Chemother. 2005. PMID: 15917286
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
Torti C, Lapadula G, Uccelli MC, Quiros-Roldan E, Regazzi M, Ladisa N, Micheli V, Orani A, Patroni A, Caputo SL, Tirelli V, Di Giambenedetto S, Cologni G, Costarelli S, Gargiulo F, Manca N, Carosi G; RADAR Study Group of MASTER Cohort. Torti C, et al. Among authors: patroni a. Int J Antimicrob Agents. 2007 Feb;29(2):185-90. doi: 10.1016/j.ijantimicag.2006.08.015. Epub 2006 Oct 2. Int J Antimicrob Agents. 2007. PMID: 17011754
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.
Quiros-Roldan E, Torti C, Lapadula G, Ladisa N, Micheli V, Patroni A, Cusato M, Pierotti P, Tirelli V, Uccelli MC, Di Giambenedetto S, Castelnuovo F, Gargiulo F, Manca N, Carosi G; RADAR-Master Study Group. Quiros-Roldan E, et al. Among authors: patroni a. AIDS Patient Care STDS. 2007 Feb;21(2):92-9. doi: 10.1089/apc.2005.0037. AIDS Patient Care STDS. 2007. PMID: 17328658 Clinical Trial.
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.
Tomasoni LR, Patroni A, Torti C, Paraninfo G, Gargiulo F, Quiros-Roldan E, Uccelli MC, Airò P, Tinelli C, Carosi G, Castelli F; Brescia-MASTER Study Group. Tomasoni LR, et al. Among authors: patroni a. HIV Clin Trials. 2003 Sep-Oct;4(5):311-23. doi: 10.1310/FGMF-Y0LY-DMX8-371V. HIV Clin Trials. 2003. PMID: 14583847
42 results